ArticleTranslational lung cancer research2022

KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China.

Qianni Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.